Peter J. Larson

3.5k total citations · 2 hit papers
43 papers, 2.4k citations indexed

About

Peter J. Larson is a scholar working on Hematology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Peter J. Larson has authored 43 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 10 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Peter J. Larson's work include Hemophilia Treatment and Research (14 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Blood properties and coagulation (4 papers). Peter J. Larson is often cited by papers focused on Hemophilia Treatment and Research (14 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Blood properties and coagulation (4 papers). Peter J. Larson collaborates with scholars based in United States, United Kingdom and New Zealand. Peter J. Larson's co-authors include Katherine A. High, Roland W. Herzog, Linda B. Couto, Catherine S. Manno, Margaret V. Ragni, Alan W. Flake, Alan McClelland, Erik D. Skarsgard, Ciaran D. Scallan and Shing Jen Tai and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Peter J. Larson

41 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

2000 782 citations Mark A. Kay, Catherine S. Manno et al. Nature Genetics profile →
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B

2003 578 citations Catherine S. Manno, S Hutchison et al. Blood profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Peter J. Larson	1.3k	1.3k	562	520	295	43	2.4k
Clelia Di Serio	1.5k 1.2×	2.3k 1.8×	1.1k 2.0×	167 0.3×	495 1.7×	87	4.6k
Gerald Grütz	222 0.2×	966 0.8×	501 0.9×	264 0.5×	199 0.7×	39	2.8k
Gottfried Fischer	554 0.4×	655 0.5×	516 0.9×	1.1k 2.2×	185 0.6×	185	4.8k
M. Lynch	212 0.2×	502 0.4×	294 0.5×	344 0.7×	407 1.4×	45	2.2k
Alan G. Baxter	1.2k 0.9×	654 0.5×	978 1.7×	269 0.5×	174 0.6×	100	6.1k
Gary C. Pien	411 0.3×	505 0.4×	739 1.3×	196 0.4×	276 0.9×	21	3.5k
Seema S. Ahuja	322 0.3×	918 0.7×	979 1.7×	158 0.3×	575 1.9×	71	4.4k
K W Sell	326 0.3×	909 0.7×	440 0.8×	127 0.2×	299 1.0×	63	3.4k
Francesco Fagnoni	279 0.2×	1.2k 1.0×	1.8k 3.2×	329 0.6×	147 0.5×	46	5.4k
Abdelhadi Saoudi	315 0.2×	530 0.4×	387 0.7×	121 0.2×	154 0.5×	100	3.4k

Countries citing papers authored by Peter J. Larson

Since Specialization

Citations

This map shows the geographic impact of Peter J. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Larson more than expected).

Fields of papers citing papers by Peter J. Larson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Larson. The network helps show where Peter J. Larson may publish in the future.

Co-authorship network of co-authors of Peter J. Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Larson. A scholar is included among the top collaborators of Peter J. Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Larson. Peter J. Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cruz, D., et al.. (2024). Drug delivery systems for wound healing treatment of upper airway injury. Expert Opinion on Drug Delivery. 21(4). 573–591. 5 indexed citations

Guan, Changhui, Peter J. Larson, Elizabeth Fleming, et al.. (2022). Engineering a “detect and destroy” skin probiotic to combat methicillin-resistant Staphylococcus aureus. PLoS ONE. 17(12). e0276795–e0276795. 12 indexed citations

Larson, Peter J., et al.. (2020). Challenges in Developing a Human Model System for Skin Microbiome Research. Journal of Investigative Dermatology. 141(1). 228–231.e4. 27 indexed citations

Zhou, Wei, Rachel Hardy, Changhui Guan, et al.. (2020). Host-Specific Evolutionary and Transmission Dynamics Shape the Functional Diversification of Staphylococcus epidermidis in Human Skin. Cell. 180(3). 454–470.e18. 96 indexed citations

McKenney, Peter T., Jinyuan Yan, Julien Vaubourgeix, et al.. (2018). Bile Acid Induced Morphotype Switch Mediates Intestinal Colonization in Vancomycin Resistant <i>Enterococcus</i>. SSRN Electronic Journal. 1 indexed citations

Walmsley, Sharon, Anchalee Avihingsanon, Jihad Slim, et al.. (2009). Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(4). 367–374. 76 indexed citations

Lalezari, Jacob, et al.. (2008). An Open-Label Safety Study of Enfuvirtide Injection with a Needle-Free Injection Device or Needle/Syringe: The Biojector 2000 Open-Label Safety Study (BOSS). AIDS Research and Human Retroviruses. 24(6). 805–813. 6 indexed citations

Gill, Joan Cox, Chantal Rothschild, Marilyn J. Manco‐Johnson, et al.. (2005). Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A. Thrombosis and Haemostasis. 93(3). 457–467. 79 indexed citations

Whinna, Herbert C., et al.. (2004). Role of the γ‐carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin–heparin. Journal of Thrombosis and Haemostasis. 2(7). 1127–1134. 6 indexed citations

10.

Manco‐Johnson, M., et al.. (2004). Development and validation of a measure of disease‐specific quality of life in young children with haemophilia. Haemophilia. 10(1). 34–41. 33 indexed citations

11.

Stonebraker, Jeffrey S., et al.. (2004). Modelling haemophilia epidemiology and treatment modalities to estimate the unconstrained factor VIII demand. Haemophilia. 10(1). 18–26. 17 indexed citations

12.

Manno, Catherine S., S Hutchison, Peter J. Larson, et al.. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood. 101(8). 2963–2972. 578 indexed citations breakdown →

13.

Jiang, Rulan, et al.. (2002). Manufacturing challenges in the commercial production of recombinant coagulation factor VIII. Haemophilia. 8(s2). 1–5. 30 indexed citations

14.

Larson, Peter J., et al.. (2001). Gene Therapy for Hemophilia B: Aav-Mediated Transfer of The Gene for Coagulation Factor IX to Human Muscle. Advances in experimental medicine and biology. 489. 45–57. 14 indexed citations

15.

Kay, Mark A., Catherine S. Manno, Margaret V. Ragni, et al.. (2000). Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nature Genetics. 24(3). 257–261. 782 indexed citations breakdown →

16.

Buckwalter, J. Galen, Ulrich Neumann, Clint Chua, et al.. (1999). Virtual Environments for Targeting Cognitive Processes: An Overview of Projects at the University of Southern California. CyberPsychology & Behavior. 2(2). 89–100. 17 indexed citations

17.

Larson, Peter J., A. A. Rizzo, J. Galen Buckwalter, et al.. (1999). Gender Issues in the Use of Virtual Environments. CyberPsychology & Behavior. 2(2). 113–123. 36 indexed citations

18.

Rizzo, Albert, J. Galen Buckwalter, Ulrich Neumann, et al.. (1998). The Virtual Reality Mental Rotation Spatial Skills Project. CyberPsychology & Behavior. 1(2). 113–119. 35 indexed citations

19.

Larson, Peter J., et al.. (1996). Delayed hemolytic transfusion reaction due to anti-Goa, an antibody against the low-prevalence Gonzales antigen. American Journal of Hematology. 53(4). 248–250. 16 indexed citations

20.

Larson, Peter J., John Thorp, Richard C. Miller, & Maureane Hoffman. (1995). The Monocyte Monolayer Assay: A Noninvasive Technique for Predicting the Severity of in Utero Hemolysis. American Journal of Perinatology. 12(3). 157–160. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact